(CercleFinance.com) – Pixium Vision, whose market capitalization has collapsed in recent years, announced on Thursday the completion of the plan to regroup its shares.
The bioelectronics company offered its shareholders one new share with a par value of one euro, compared to 50 old shares with a par value of 0.02 euros.
The number of shares making up its capital will therefore increase from 154 million to just over three million following the operation, which was approved last July by the board of directors.
For the first day of admission to trading of the shares resulting from the merger, the title of the specialist in vision systems for patients who have lost their sight fell by more than 15%.
Introduced on the stock market at a price of eight euros in 2014, the action reached a low of 0.03 euros this year, before rebounding following obtaining ‘innovative’ device status from the American FDA for its Prima system in the treatment of dry AMD.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
This is a Smartvoice article: see legal notices